Effect of pure microsteatosis on transplant outcomes after living donor liver transplantation: A matched case-control study

Liver Transplantation

Volumn 20, Issue 4, 2014, Pages 473-482

  Han, Sangbin ^a   Ko, Justin Sangwook ^a   Kwon, Gheeyoung ^a   Park, Cheolkeun ^a   Lee, Sanghoon ^a   Kim, Jongman ^a   Kim, Gaabsoo ^a   Kwon, Choonhyuck David ^a   Gwak, Misook ^a   Ha, Sangyun ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE;

ADULT; AGE; ALCOHOL LIVER CIRRHOSIS; ARTICLE; AUTOIMMUNE HEPATITIS; COLD ISCHEMIA; CONTROLLED STUDY; CRYPTOGENIC CIRRHOSIS; FATTY LIVER; FEMALE; GRAFT DYSFUNCTION; GRAFT RECIPIENT; GRAFT SURVIVAL; HOSPITALIZATION; HUMAN; HUMAN TISSUE; INTENSIVE CARE UNIT; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LIVER WEIGHT; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MICROSTEATOSIS; MODEL FOR END STAGE LIVER DISEASE SCORE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; STEATOSIS; TREATMENT OUTCOME; YOUNG ADULT; CASE CONTROL STUDY; END STAGE LIVER DISEASE; LIVER FAILURE; MIDDLE AGED; PROCEDURES; REGENERATION;

ADULT; CASE-CONTROL STUDIES; END STAGE LIVER DISEASE; FATTY LIVER; FEMALE; GRAFT SURVIVAL; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; REGENERATION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84897116111     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23824     Document Type: Article

References (34)

1. Koneru B, Dikdan G,. Hepatic steatosis and liver transplantation current clinical and experimental perspectives. Transplantation 2002; 73: 325-330.
2. Selzner M, Clavien PA,. Fatty liver in liver transplantation and surgery. Semin Liver Dis 2001; 21: 105-113.
3. Jolly RA, Ciurlionis R, Morfitt D, Helgren M, Patterson R, Ulrich RG, Waring JF,. Microvesicular steatosis induced by a short chain fatty acid: effects on mitochondrial function and correlation with gene expression. Toxicol Pathol 2004; 32 (suppl 2): 19-25.
4. Burke A, Lucey MR,. Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation. Am J Transplant 2004; 4: 686-693.
5. Fishbein TM, Fiel MI, Emre S, Cubukcu O, Guy SR, Schwartz ME, et al. Use of livers with microvesicular fat safely expands the donor pool. Transplantation 1997; 64: 248-251.
6. Crowley H, Lewis WD, Gordon F, Jenkins R, Khettry U,. Steatosis in donor and transplant liver biopsies. Hum Pathol 2000; 31: 1209-1213.
7. Selzner N, Selzner M, Jochum W, Amann-Vesti B, Graf R, Clavien PA,. Mouse livers with macrosteatosis are more susceptible to normothermic ischemic injury than those with microsteatosis. J Hepatol 2006; 44: 694-701.
8. Dutkowski P, Schlegel A, Slankamenac K, Oberkofler CE, Adam R, Burroughs AK, et al. The use of fatty liver grafts in modern allocation systems: risk assessment by the balance of risk (BAR) score. Ann Surg 2012; 256: 861-868.
9. Cieślak B, Lewandowski Z, Urban M, Ziarkiewicz-Wrõblewska B, Krawczyk M,. Microvesicular liver graft steatosis as a risk factor of initial poor function in relation to suboptimal donor parameters. Transplant Proc 2009; 41: 2985-2988.
10. Noujaim HM, de Ville de Goyet J, Montero EF, Ribeiro CM, Capellozzi VL, Crescentini F, et al. Expanding postmortem donor pool using steatotic liver grafts: a new look. Transplantation 2009; 87: 919-925.
11. Marcos A, Fisher RA, Ham JM, Shiffman ML, Sanyal AJ, Luketic VA, et al. Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation. Transplantation 2000; 69: 1375-1379.
12. Miller CM, Gondolesi GE, Florman S, Matsumoto C, Muñoz L, Yoshizumi T, et al. One hundred nine living donor liver transplants in adults and children: a single-center experience. Ann Surg 2001; 234: 301-311.
13. Williams RS, Alisa AA, Karani JB, Muiesan P, Rela SM, Heaton ND,. Adult-to-adult living donor liver transplant: UK experience. Eur J Gastroenterol Hepatol 2003; 15: 7-14.
14. McCormack L, Petrowsky H, Jochum W, Furrer K, Clavien PA,. Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy: a matched case-control study. Ann Surg 2007; 245: 923-930.
15. McCormack L, Clavien PA,. Understanding the meaning of fat in the liver. Liver Transpl 2005; 11: 137-139.
16. Tannapfel A, Denk H, Dienes HP, Langner C, Schirmacher P, Trauner M, Flott-Rahmel B,. Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease. Virchows Arch 2011; 458: 511-523.
17. Cepeda MS, Boston R, Farrar JT, Strom BL,. Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders. Am J Epidemiol 2003; 158: 280-287.
18. Austin PC, Grootendorst P, Anderson GM,. A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study. Stat Med 2007; 26: 734-753.
19. Standish RA, Cholongitas E, Dhillon A, Burroughs AK, Dhillon AP,. An appraisal of the histopathological assessment of liver fibrosis. Gut 2006; 55: 569-578.
20. Cho JY, Suh KS, Lee HW, Cho EH, Yang SH, Cho YB, et al. Hypoattenuation in unenhanced CT reflects histological graft dysfunction and predicts 1-year mortality after living donor liver transplantation. Liver Transpl 2006; 12: 1403-1411.
21. McCormack L, Petrowsky H, Jochum W, Mullhaupt B, Weber M, Clavien PA,. Use of severely steatotic grafts in liver transplantation: a matched case-control study. Ann Surg 2007; 246: 940-946.
22. Clavien PA, Camargo CA Jr, Croxford R, Langer B, Levy GA, Greig PD,. Definition and classification of negative outcomes in solid organ transplantation. Application in liver transplantation. Ann Surg 1994; 220: 109-120.
23. Pagadala M, Dasarathy S, Eghtesad B, McCullough AJ,. Posttransplant metabolic syndrome: an epidemic waiting to happen. Liver Transpl 2009; 15: 1662-1670.
24. Imamura H, Takayama T, Sugawara Y, Kokudo N, Aoki T, Kaneko J, et al. Pringle's manoeuvre in living donors. Lancet 2002; 360: 2049-2050.
25. Spitzer AL, Lao OB, Dick AA, Bakthavatsalam R, Halldorson JB, Yeh MM, et al. The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment. Liver Transpl 2010; 16: 874-884.
26. Selzner M, Clavien PA,. Failure of regeneration of the steatotic rat liver: disruption at two different levels in the regeneration pathway. Hepatology 2000; 31: 35-42.
27. Dahm F, Georgiev P, Clavien PA,. Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications. Am J Transplant 2005; 5: 2605-2610.
28. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al.; for Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313-1321.
29. Ninomiya M, Shimada M, Terashi T, Ijichi H, Yonemura Y, Harada N, et al. Sustained spatial disturbance of bile canalicular networks during regeneration of the steatotic rat liver. Transplantation 2004; 77: 373-379.
30. Cho JY, Suh KS, Lee HW, Cho EH, Yang SH, Cho YB, et al. Hepatic steatosis is associated with intrahepatic cholestasis and transient hyperbilirubinemia during regeneration after living donor liver transplantation. Transpl Int 2006; 19: 807-813.
31. Suzuki S, Nakamura S, Sakaguchi T, Ochiai H, Konno H, Baba S, Baba S,. Alteration of reticuloendothelial phagocytic function and tumor necrosis factor-alpha production after total hepatic ischemia. Transplantation 1997; 64: 821-827.
32. Schindl MJ, Redhead DN, Fearon KC, Garden OJ, Wigmore SJ,; for Edinburgh Liver Surgery and Transplantation Experimental Research Group (eLISTER). The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut 2005; 54: 289-296.
33. Fromenty B, Berson A, Pessayre D,. Microvesicular steatosis and steatohepatitis: role of mitochondrial dysfunction and lipid peroxidation. J Hepatol 1997; 26 (suppl 1): 13-22.
34. Li J, Liu B, Yan LN, Zuo YX, Li B, Zeng Y, et al. Reversal of graft steatosis after liver transplantation: prospective study. Transplant Proc 2009; 41: 3560-3563.